SLT (CognivAiD™) Improves Memory and Cognition in Individuals With Mild Cognitive Impairment: Clinical Trial Results
09. November 2023 04:22 ET
|
Moleac Pte Ltd
Investigator-initiated clinical trial of SLT (CognivAiDTM) for mild cognitive impairment (MCI) reported significant improvement in key cognitive domains.
CAGR of 5.24% | Global Mild Cognitive Impairment Market Size To Grow USD 3.5 Billion By 2032
20. April 2023 08:50 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 20, 2023 (GLOBE NEWSWIRE) -- The Global Mild Cognitive Impairment (MCI) Market Size is To Grow from USD 2.1 Billion in 2022 to USD 3.5 Billion by 2032, at a Compound...
Cognitive Decline Market is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031)
25. April 2022 09:00 ET
|
Persistence Market Research
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to...
Study: New Intervention Helps with Alcohol-related Cognitive Impairment
14. Dezember 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related...
New Study: Brain Exercises Drive Gains in Pre-Dementia Patients
16. März 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, March 16, 2020 (GLOBE NEWSWIRE) -- A newly published imaging study in NeuroImage from researchers at the University of Rochester has shown that brain training drove improvements in...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
29. März 2017 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
DiamiR Provides Update on Its Patent Portfolio, Launches New Website
26. September 2016 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - September 26, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, reported today that...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21. Juli 2016 08:30 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
18. März 2016 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...
DiamiR Announces Research Collaboration With Johnson & Johnson Innovation
11. Januar 2016 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - January 11, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests, announced today that it has entered into a research...